Follow
Spencer Phillips Hey
Spencer Phillips Hey
Prism Analytic Technologies
Verified email at prism.bio - Homepage
Title
Cited by
Cited by
Year
Assessment of the clinical benefit of cancer drugs receiving accelerated approval
B Gyawali, SP Hey, AS Kesselheim
JAMA Internal Medicine 179 (7), 906-913, 2019
2412019
A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology
A Haslam, SP Hey, J Gill, V Prasad
European Journal of Cancer 106, 196-211, 2019
1702019
Are outcome-adaptive allocation trials ethical?
SP Hey, J Kimmelman
Clinical Trials 12 (2), 102-106, 2015
1172015
The questionable use of unequal allocation in confirmatory trials
SP Hey, J Kimmelman
Neurology 82 (1), 77-79, 2014
1152014
Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs
B Gyawali, SP Hey, AS Kesselheim
EClinicalMedicine 21, 2020
1062020
Assessment of the role of niacin in managing cardiovascular disease outcomes: a systematic review and meta-analysis
E D’Andrea, SP Hey, CL Ramirez, AS Kesselheim
JAMA network open 2 (4), e192224-e192224, 2019
802019
Benefit, risk, and outcomes in drug development: a systematic review of sunitinib
B Carlisle, N Demko, G Freeman, A Hakala, N MacKinnon, T Ramsay, ...
Journal of the National Cancer Institute 108 (1), djv292, 2016
692016
A comparison of response patterns for progression-free survival and overall survival following treatment for cancer with PD-1 inhibitors: a meta-analysis of correlation and …
B Gyawali, SP Hey, AS Kesselheim
JAMA Network Open 1 (2), e180416-e180416, 2018
662018
Is the concept of clinical equipoise still relevant to research?
SP Hey, AJ London, C Weijer, A Rid, F Miller
BMJ 359, 2017
432017
Countering imprecision in precision medicine
SP Hey, AS Kesselheim
Science 353 (6298), 448-449, 2016
412016
The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders
SG Nicholls, K Carroll, M Zwarenstein, JC Brehaut, C Weijer, SP Hey, ...
Trials 20, 1-16, 2019
372019
Heuristics and Meta-heuristics in Scientific Judgement
SP Hey
The British Journal for the Philosophy of Science 67 (2), 471-495, 2014
372014
Cell and gene therapy trials: are we facing an ‘evidence crisis’?
M Abou-El-Enein, SP Hey
EClinicalMedicine 7, 13-14, 2019
352019
A Systematic Review Of The Food And Drug Administration’s ‘Exception From Informed Consent’ Pathway
WB Feldman, SP Hey, AS Kesselheim
Health Affairs 37 (10), 1605-1614, 2018
342018
Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
E D’Andrea, AS Kesselheim, JM Franklin, EH Jung, SP Hey, E Patorno
Cardiovascular Diabetology 19, 1-11, 2020
312020
Cluster over individual randomization: are study design choices appropriately justified? Review of a random sample of trials
M Taljaard, CE Goldstein, B Giraudeau, SG Nicholls, K Carroll, SP Hey, ...
Clinical Trials 17 (3), 253-263, 2020
312020
A framework for assessing scientific merit in ethical review of clinical research
A Binik, SP Hey
Ethics & human research 41 (2), 2-13, 2019
272019
A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing
SG Nicholls, K Carroll, SP Hey, M Zwarenstein, JZ Zhang, HP Nix, ...
Journal of clinical epidemiology 137, 45-57, 2021
262021
Public approval of exception from informed consent in emergency clinical trials: a systematic review of community consultation surveys
WB Feldman, SP Hey, JM Franklin, AS Kesselheim
JAMA Network Open 2 (7), e197591-e197591, 2019
262019
Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol
M Taljaard, C Weijer, JM Grimshaw, A Ali, JC Brehaut, MK Campbell, ...
Trials 19, 1-13, 2018
262018
The system can't perform the operation now. Try again later.
Articles 1–20